HUE049682T2 - Új eljárások vemurafenib elõállítására - Google Patents

Új eljárások vemurafenib elõállítására

Info

Publication number
HUE049682T2
HUE049682T2 HUE17745368A HUE17745368A HUE049682T2 HU E049682 T2 HUE049682 T2 HU E049682T2 HU E17745368 A HUE17745368 A HU E17745368A HU E17745368 A HUE17745368 A HU E17745368A HU E049682 T2 HUE049682 T2 HU E049682T2
Authority
HU
Hungary
Prior art keywords
vemurafenib
preparation
new processes
processes
new
Prior art date
Application number
HUE17745368A
Other languages
English (en)
Inventor
Antti Kataja
Original Assignee
Fermion Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fermion Oy filed Critical Fermion Oy
Publication of HUE049682T2 publication Critical patent/HUE049682T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HUE17745368A 2016-07-01 2017-06-30 Új eljárások vemurafenib elõállítására HUE049682T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20165557 2016-07-01
FI20165778 2016-10-12

Publications (1)

Publication Number Publication Date
HUE049682T2 true HUE049682T2 (hu) 2020-10-28

Family

ID=59416718

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE17745368A HUE049682T2 (hu) 2016-07-01 2017-06-30 Új eljárások vemurafenib elõállítására

Country Status (10)

Country Link
US (1) US10407427B2 (hu)
EP (1) EP3478684B1 (hu)
JP (1) JP6911062B2 (hu)
CA (1) CA3029361A1 (hu)
ES (1) ES2802476T3 (hu)
HR (1) HRP20200821T1 (hu)
HU (1) HUE049682T2 (hu)
PL (1) PL3478684T3 (hu)
RS (1) RS60451B1 (hu)
WO (1) WO2018002415A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018134254A1 (en) 2017-01-17 2018-07-26 Heparegenix Gmbh Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
WO2020070390A1 (en) 2018-10-03 2020-04-09 Jyväskylän Yliopisto Vemurafenib and salts thereof for use in the treatment of enteroviral infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3088400A1 (en) 2005-06-22 2016-11-02 Plexxikon Inc. Pyrrolo[2,3-b]pyridine derivatives as protein kinase inhibitors
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
US8779150B2 (en) 2010-07-21 2014-07-15 Hoffmann-La Roche Inc. Processes for the manufacture of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1 H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide
CN105008356A (zh) 2013-03-14 2015-10-28 拉蒂奥法姆有限责任公司 固态形式的盐酸威罗菲尼
WO2015075749A1 (en) 2013-11-22 2015-05-28 Laurus Labs Private Limited Novel processes for the preparation of vemurafenib
CZ2013943A3 (cs) 2013-11-27 2015-06-03 Zentiva, K.S. Krystalické formy vemurafenibu
WO2016083956A1 (en) 2014-11-29 2016-06-02 Shilpa Medicare Limited Substantially pure vemurafenib and its salts

Also Published As

Publication number Publication date
JP2019522662A (ja) 2019-08-15
PL3478684T3 (pl) 2020-08-10
CA3029361A1 (en) 2018-01-04
WO2018002415A1 (en) 2018-01-04
JP6911062B2 (ja) 2021-07-28
ES2802476T3 (es) 2021-01-19
RS60451B1 (sr) 2020-07-31
US20190194197A1 (en) 2019-06-27
US10407427B2 (en) 2019-09-10
EP3478684A1 (en) 2019-05-08
EP3478684B1 (en) 2020-04-15
HRP20200821T1 (hr) 2020-08-07

Similar Documents

Publication Publication Date Title
SI3433285T1 (sl) Izboljšan postopek za pripravo sugamadeksa
HK1246776A1 (zh) 用於hiv治療的異喹啉化合物
ZA201706795B (en) Process for the preparation of dicycloplatin
HK1257272A1 (zh) 治療hiv的工具
HK1247558A1 (zh) 塞內可瑞偉洛克(cenicriviroc)用於治療纖維化
IL268835B (en) A process for the preparation of 2-cyanoimidazole compounds
IL275480A (en) A process for the preparation of pyrimidinyl-4-aminopyrazole compounds
PL3228619T3 (pl) Sposób wytwarzania apiksabanu
PL3478684T3 (pl) Nowe sposoby otrzymywania wemurafenibu
IL260070B (en) A method for the preparation of converted 2-aryl-ethanols
IL247443B (en) Process for the preparation of 5-fluorotryptophol
HUE057882T2 (hu) Eljárás karbodiimidek elõállítására
EP3474847A4 (en) METHOD FOR PRODUCING ELUXADOLIN
HUE053496T2 (hu) Eljárás izocianátok elõállítására
HUP1400518A2 (hu) Eljárás tofacitinib elõállítására
PT3102565T (pt) Processos para a preparação de intermediários de raltegravir
HK1258181A1 (zh) 製備螯合劑的方法
EP3515434A4 (en) METHOD FOR PRODUCING ELUXADOLIN
GB2587294B (en) Processes for the preparation of desflurane
IL253562B (en) A method for the preparation of tyrazoles
EP3344249A4 (en) Processes for the preparation of ivacaftor